Twenty-five years ago today, ICR researchers made the historic discovery of the BRCA2 gene, involved in familial risk of breast, ovarian and prostate cancer. Juanita Bawagan recounts some of their ...

Carriers of BRCA2 mutants have a similar risk of breast cancer and a more moderately increased risk of ovarian cancer. BRCA1 and BRCA2, located on the long arms of chromosomes 17 and 13 ...

Image credit: Anne Weston, Francis Crick Institute. Licence: CC BY-NC. Guidelines should change so that all men over the age of 40 with faults in the BRCA2 gene should be offered regular PSA testing ...

The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2 ...